Tuesday, 17 January 2017

Barriers, beliefs and practice patterns for breast cancer reconstruction: A provincial survey

Barriers, beliefs and practice patterns for breast cancer reconstruction: A provincial survey

The Breast: April 2017Volume 32, Pages 60–65
Coroneos CJ et al

The purpose of this study was to characterize beliefs and practice patterns for breast cancer reconstruction among physicians who treat patients with breast cancer, in order to delineate current clinical practice. This survey was administered prior to Cancer Care Ontario guideline publication.

Pathological complete response in invasive breast cancer treated by skin sparing mastectomy and immediate reconstruction following neoadjuvant chemotherapy and radiation therapy: Comparison between immunohistochemical subtypes

Pathological complete response in invasive breast cancer treated by skin sparing mastectomy and immediate reconstruction following neoadjuvant chemotherapy and radiation therapy: Comparison between immunohistochemical subtypes
The Breast: April 2017Volume 32, Pages 37–43
Barrou J et al

Even if neoadjuvant chemotherapy (NACT) and oncoplastic techniques have increased the breast conserving surgery rate, mastectomy is still a standard for multifocal or extensive breast cancers (BC). In the prospect of increasing breast reconstruction, an alternative therapeutic protocol was developed combining NACT with neoadjuvant radiation therapy (NART), followed by mastectomy with immediate breast reconstruction (IBR). The oncological safety of this therapeutic plan still needs further exploration.

Breast reconstruction after mastectomy: A ten-year analysis of trends and immediate postoperative outcomes

Breast reconstruction after mastectomy: A ten-year analysis of trends and immediate postoperative outcomes
The Breast: April 2017Volume 32, Pages 7–12
Ilonzo N et al

The landscape of breast reconstruction has changed significantly. This study assesses trends in type of reconstruction performed after mastectomy and impact on immediate postoperative complications.

Reducing implant loss rates in immediate breast reconstructions

Reducing implant loss rates in immediate breast reconstructions
The Breast: February 2017Volume 31, Pages 208–213
Darragh L et al

UK best practice guidelines for oncoplastic breast reconstruction were published in 2012. Implant-based reconstruction quality indicator (QI) targets for readmission, return to theatre and implant loss rates were set at 5% by 3 months, along with guidance to achieve these targets. The aims of this study were to quantify complication rates following implant-based reconstruction before and after the implementation of the guidelines. A retrospective audit of 86 patients with 106 implants in the 12 months to June 2013 was performed, C1.

Over surgery in breast cancer

Over surgery in breast cancer

The Breast: February 2017 Volume 31, Pages 284–289
MacNeill F


Breast surgery remains the original and most effective ‘targeted’ therapy: excision of early cancer is curative and for more advanced disease surgery improves local disease control. However in well intentioned pursuit of cure and local disease control, some cancers are over-treated resulting in major physical and emotional morbidity.Less breast surgery is safe, as evidenced by steady reductions in mortality and local recurrence; earlier diagnosis and widespread use of systemic therapies and radiotherapy have allowed more conservative surgery.